U-Blot® Research Grade CixutumumabCat. No. WA2608$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade CixutumumabCat. No. WA2608
U-Blot® Research Grade CitatuzumabCat. No. WA2607
U-Blot® Research Grade CirevetmabCat. No. WA2606
U-Blot® Research Grade Cinrebafusp alfaCat. No. WA2605
U-Blot® Research Grade CinpanemabCat. No. WA2604
U-Blot® Research Grade ciltistotugCat. No. WA2603
U-Blot® Research Grade CilgavimabCat. No. WA2602
U-Blot® Research Grade ciletatugCat. No. WA2601
U-Blot® Research Grade CifurtilimabCat. No. WA2600
U-Blot® Research Grade CiduvectamigCat. No. WA2599
U-Blot® Research Grade CiboterceptCat. No. WA2598
U-Blot® Research Grade CibisatamabCat. No. WA2597